Endocrine Therapy for Prostate Cancer: Recent Developments and Current Status
- 1 June 1993
- journal article
- review article
- Published by Wiley in British Journal of Urology
- Vol. 71 (6) , 633-640
- https://doi.org/10.1111/j.1464-410x.1993.tb16056.x
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Orchidectomy versus buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843The Journal of Steroid Biochemistry and Molecular Biology, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Is Delayed Treatment Justified in Carcinoma of the Prostate?British Journal of Urology, 1985
- Diet and serum sex hormones in healthy menJournal of Steroid Biochemistry, 1984
- New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgensThe Prostate, 1983
- Geographic pathology of latent prostatic carcinomaInternational Journal of Cancer, 1982
- Prostatic Carcinoma Cured with Hormonal TreatmentScandinavian Journal of Urology and Nephrology, 1981
- Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, FranceInternational Journal of Cancer, 1977
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974
- Latent carcinoma of the prostateThe Journal of Pathology and Bacteriology, 1954